U.S. Markets open in 3 hrs 50 mins

Prometheus Biosciences, Inc. (RXDX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
58.25+4.72 (+8.82%)
At close: 04:00PM EDT
60.00 +1.75 (+3.00%)
Pre-Market: 04:20AM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close53.53
Bid0.00 x 1000
Ask0.00 x 1400
Day's Range53.88 - 58.78
52 Week Range21.50 - 59.74
Avg. Volume544,734
Market Cap2.268B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-3.13
Earnings DateMay 13, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est53.91
  • Motley Fool

    Can This Tiny Biotech Take On Pfizer?

    Undaunted by a potential battle with a goliath like Pfizer, Prometheus is developing PRA023, an experimental treatment for inflammatory bowel disease. Prometheus' candidate could eventually generate billions in annual revenue, but it will have to overcome PF-06480605, a similar candidate from Pfizer. Can Prometheus take on Pfizer in the lucrative space for inflammatory bowel disease treatments?

  • InvestorPlace

    7 Top-Rated Biotech Stocks to Buy for Q4

    A new White House program will likely boost the entire biotech industry. And it makes these seven names some outstanding biotech stocks to buy for the fourth quarter. The new National Biotechnology and Biomanufacturing Initiative is designed to encourage biotech production in the U.S. An executive order signed by President Joe Biden on Sept. 12, was followed by a White House summit featuring Cabinet-level initiatives that will increase the nation’s biotech and biomanufacturing capabilities. This

  • Insider Monkey

    12 Best IPO Stocks to Invest In Right Now

    In this piece, we will take a look at the twelve best stocks that have recently had their initial public offering. If you want to jump ahead to the top five stocks in this list, then head on over to 5 Best IPO Stocks to Invest In Right Now. IPO activity in the United States […]